International Cannabis Weekly: 161

• Will cannabis help in the fight against COVID-19? Prohibition Partners dive deeper.
• US cannabis companies outperform Canada in Q2 2020 earnings.
• Federal court denies DEA’s request to dismiss cannabis rescheduling case.
• Canada is accused of protectionism by blocking cannabis imports, as exports rise.

• Cansativa receives four-year contract for German-produced medical cannabis.
• UK family seeks judicial review of NHS guidelines for the prescription of cannabis oil.
• EMMAC secures GDP licence for the distribution of medicinal cannabis in Switzerland.
• The French National Medicines Agency plans to authorise hemp flowers and leaves.
• Shareholders of Sativa Group vote in favour of Stillcanna acquisition.
• Tilray is recalling its cannabis extract again in Germany.
• Different interpretations of tax law in Poland give competitive advantage.

ACCESS EXCLUSIVE INSIGHTS

• Money managers are investing in cannabis stocks ahead of US elections.
• State treasurers seek cannabis banking reform in next COVID-19 relief package.
• Texas judge temporarily lifts the ban on selling smokable hemp products.
• Maine will commence retail sales of adult-use cannabis on 9 October.
• Vermont lawmakers announce they are finalising a bill to legalise cannabis sales.
• Top law-enforcement officials publicly urge Congress to decriminalise cannabis.
• Dutchie, a cannabis e-commerce platform, completes Series B funding round.
• Florida-based REIT raises US$80 million in capital to lend to cannabis operators.
• Curaleaf reports an increase of 22% in total revenue in Q2 2020 results.

• Canadian inventory of cannabis edibles and beverages dramatically outpaces sales.
• Aphria plans to acquire non-cannabis US brands to build out cannabis capabilities.
• Canadian cannabis companies tackle illicit markets with competitive prices.
• Avicanna reports an increase of 172% in revenue in Q2 2020 results.
• Adastra announces supply agreement of cannabis biomass with Pure Sunfarms.

• Mexico’s president maintains there will be legal reform for the regulation of cannabis.
• Cplant seeks to raise US$10 million to fund cannabis retail expansion.
• Uruguay’s cannabis companies estimate medical exports will reach US$1 billion.
• Argentina’s federal court no longer considers cannabis as a narcotic.

• New Zealand delays general election and cannabis referendum by a month.
• Rua Bioscience get commercial licence for cannabis-derived medicines & plans IPO.
• MediPharm receives licence to manufacture API derived from cannabis in Australia.
• Cannatrek receives medical cannabis shipment from Clever Leaves.
• MGC Pharmaceuticals releases results for treatment of COVID-19.
• Cann Group share purchase plan (SSP) oversubscribed by $10m.

• South African government invests ZAR10 million into the regional cannabis industry.
• PAO Group is seeking Israeli R&D partners for cannabis respiratory treatment.
• Organigram sends its first shipment of indoor-grown cannabis flower to Canndoc.

The link between COVID-19 and cannabis may seem tenuous, but what if there is a serious potential for the plant to become a global solution? Read the full analysis from Prohibition Partners, here.

Read the full analysis from Prohibition Partners, here.